Expanding Product Portfolio Bausch + Lomb is actively launching new consumer and clinical products such as Blink Hygiene Daily Eyelid Wipes and Soothe Antibiotic Drops, indicating ongoing growth and innovation that could present upselling opportunities in eye and ear care markets.

Strategic Collaborations The company's collaborations with Ripple Therapeutics and Collaborations Pharmaceuticals highlight a focus on developing advanced treatments through licensing, AI integration, and sustained-release implants, opening avenues for partnership in innovative ophthalmic solutions.

Focus on Eye Health Innovation Investments in R&D and partnerships aimed at developing sustained-release implants and AI-driven drug discovery suggest a robust pipeline that can be leveraged to introduce cutting-edge technologies and expand product offerings.

Global Market Presence With operations in nearly 100 countries and a diverse portfolio of over 400 products, Bausch + Lomb offers extensive geographic and product expansion opportunities for sales teams targeting ophthalmic clinicians, hospitals, and retail sectors worldwide.

Financial Scale and Reach Generating between one and ten billion dollars in revenue with a strong employer base, Bausch + Lomb remains a significant player in pharmaceutical manufacturing, providing a solid foundation for strategic sales engagement across multiple touchpoints in the eye care industry.